SVA

Sinovac Biotech, Ltd
SVA

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

SVA was delisted on the 22nd of February, 2019.

Back to rankings

9 hedge funds and large institutions have $418M invested in Sinovac Biotech, Ltd in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1
-$849K
2
-$106K
3
-$89.7K
4
Wells Fargo
Wells Fargo
California
-$80.6K
5
Morgan Stanley
Morgan Stanley
New York
-$50.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$340M
2
$76.3M
3
$2.04M
4
$336
5
–
6
–
7
–
8
–
9
–
10
–
11
–